Records containing: Idiopathic Pulmonary Fibrosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-05-31Clinical, Radiological Characteristics and Health Related Quality of Life in Idiopathic Pulmonary Fibrosis Patients
-
CLINICAL_TRIALS study record update · 2017-05-15A Phase 2, Randomized Dose-ranging Study to Evaluate the Efficacy of Tralokinumab in Adults With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2017-05-15Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis With Thalidomide
-
CLINICAL_TRIALS study record update · 2017-05-08Multi-center Open-label Expanded Access Program of Oral Nintedanib 150 mg Twice Daily in Patients With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2017-05-01A FTIH Study With GSK3008348 in Healthy Volunteers and Patients With Idiopathic Pulmonary Fibrosis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-04-28Prospective Evaluation of Patients With Idiopathic Pulmonary Fibrosis Through an IPF Registry
-
CLINICAL_TRIALS study record update · 2017-04-21Post-Authorisation Safety Study of Esbriet® (Pirfenidone): A Prospective Observational Registry to Evaluate Long-Term Safety in a Real-World Setting
-
CLINICAL_TRIALS study record update · 2017-04-19The Registry of Controls for Respiratory Diseases
-
CLINICAL_TRIALS study record update · 2017-04-13A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
-
CLINICAL_TRIALS study record update · 2017-04-07Safety and Diagnostic Performance of 68Ga-BMV101 PET/CT in Patients With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2017-04-04A Phase 2, Long-Term Safety Study of GS-6624 in Adult Subjects With Idiopathic Pulmonary Fibrosis (IPF)
-
CLINICAL_TRIALS study record update · 2017-03-29Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2017-03-29An Open-Label Extension Study of the Long Term Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF)
-
CLINICAL_TRIALS study record update · 2017-03-17A Study to Assess the Tolerability of a Single Dose of AF-219, a P2X3 Receptor Antagonist, in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
-
CLINICAL_TRIALS study record update · 2017-02-28Clinical Course of Treatment With ESBRIET in Patients With Mild to Moderate IPF
-
CLINICAL_TRIALS study record update · 2017-02-24The Inflammatory and Antioxidant Status in Pulmonary Sarcoidosis, Idiopathic Pulmonary Fibrosis and COPD: a Potential Role for Antioxidants
-
CLINICAL_TRIALS study record update · 2017-02-23A Phase 2, Multicenter, Double-Blind Within Cohort, Dose-escalation Study to Evaluate the Safety and Tolerability of Multiple Doses of CAT-354 (Tralokinumab) in Japanese Patients With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2016-12-23Observational Study of the Effect of Pirfenidone on Cough in Patients With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2016-11-02ClinicalTrials.gov study NCT02168530
-
CLINICAL_TRIALS study record update · 2016-09-19A Phase 2, Open-Label, Dose-Escalation Study in Subjects With Pulmonary Arterial Hypertension, (PAH, WHO Group 1) and Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis, (PH-IPF WHO Group 3) Using Inhaled GeNOsyl.
-
CLINICAL_TRIALS study record update · 2016-09-01Investigating the Role of the Coagulation Cascade in Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2016-07-01Exhaled Breath Condensate Biomarkers and Cough in People With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2016-06-13Modelling of Quality Life, Clinical and Physiological Measures in Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2016-05-20A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Safety and Tolerability of N-Acetylcysteine in Patients With Idiopathic Pulmonary Fibrosis With Background Treatment of Pirfenidone
-
CLINICAL_TRIALS study record update · 2016-03-09An Open-Label, Phase 2 Study of the Safety of Oral Pirfenidone in Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis